Skip to content

ENB for the Diagnosis of PPNs:a Real World Study

Electromagnetic Navigation Bronchoscopy for the Diagnosis of Peripheral Pulmonary Nodules: a Real World Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03716284
Enrollment
479
Registered
2018-10-23
Start date
2019-03-20
Completion date
2022-06-30
Last updated
2022-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peripheral Pulmonary Nodules

Keywords

electromagnetic navigation bronchoscopy(ENB), peripheral pulmonary nodules, diagnostic yield

Brief summary

The study is designed as a multi-center prospective trial of ENB for the diagnosis of peripheral pulmonary nodules in the real world. The purpose of the study is to identify the optimal method of using ENB.

Detailed description

The study will be conducted at no less than 5 clinical centers. Patients with peripheral pulmonary nodules suspicious for malignancy will be enrolled in the study. ENB will be performed with/without other guided bronchoscopy techniques and/or ROSE. Different biopsy methods will be recorded as well. The primary endpoint is the diagnostic yield of ENB. The secondary endpoints include factors affecting diagnostic yield, operation time, complications, safety and so on.

Interventions

ENB is carried out by a ENB system(LungCare, China) with/without other guided bronchoscopy techniques and/or ROSE, which can offer real-time navigation for bronchoscopy reaching peripheral pulmonary nodules.

Sponsors

Air Force Military Medical University, China
CollaboratorOTHER
Xiangya Hospital of Central South University
CollaboratorOTHER
Shanghai Chest Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Patients who are older than 18 year-old. 2. Chest CT shows peripheral pulmonary nodule (8mm\<longest diameter≤30mm) suspicious for malignant that needs to be confirmed by pathology. The nodule is surrounded by lung parenchyma and invisible with standard bronchoscopy. 3. Patients who agree to undergo bronchoscopy without any contraindications. 4. Patients who have good compliance and sign informed consent.

Exclusion criteria

1. Presence of concomitant endobronchial lesion during the brochoscopy procerdure. 2. Severe cardiopulmonary dysfunction and other indications that can't receive bronchoscopy.

Design outcomes

Primary

MeasureTime frameDescription
Diagnostic yieldOne yearDiagnostic yield is defined as proportion of true positive and true negative. The primary endpoint is diagnostic yield of ENB with/without other guided bronchoscopy techniques or ROSE.

Secondary

MeasureTime frameDescription
The difference of diagnostic yield among groups of different methods of using ENBOne yearENB will be performed with/without other guided bronchoscopy techniques and/or ROSE. Different biopsy methods will be recorded as well.The difference of diagnostic yield among groups of different methods of using ENB will be analyzed.
Factors affecting diagnostic yieldOne yearFactors affecting diagnostic yield including lesion size,bronchus sign, location and so on will be analyzed.
The difference of diagnostic yield among groups using different locatable guidesOne yearThere are three kinds of locatable guides with different outer diameters. The difference of diagnostic yield among groups using different locatable guides will be analyzed.
Operation timeOne yearOperation time includes total operation time,total GS time and total EBUS time.
Incidence of complicationsOne yearComplications mean a composite of operation-related serious adverse events (pneumothorax, bleeding, etc.) during and after the operation.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026